Krónikus gyulladásos demielinizációs polineuropátia (CIDP): vizsgálatok itt: Tajvan
3 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Kaohsiung City, Taipei
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT06290141 · EU 2023-508338-33-00 - 2/3. fázisBefejeződöttEfficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Kaohsiung City, Taipei
- Életkor
- 18 év and over
- People
- 201 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05327114 · EU 2023-508425-28-00 - 3. fázisCsak meghívásosLong-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
- Where
- Taipei
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Sanofi
See details and how to joinNCT06859099 · EU 2024-517032-22-00